Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Moxifloxacin (0.5% w/v)
Therapeutic Category
Antibiotic, Ophthalmology
Dosage Form
Eye Drops
Packaging Type
vial
Packaging
5ml
Price
₹120/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Moxolunic Eye Drop (Moxifloxacin 0.5% w/v) – Broad-Spectrum Antibacterial Eye Drop
Moxolunic Eye Drop contains Moxifloxacin 0.5% w/v, a fourth-generation fluoroquinolone antibiotic used to treat bacterial eye infections. It is highly effective against conjunctivitis (pink eye), corneal ulcers, and other ocular bacterial infections by inhibiting bacterial DNA gyrase, preventing their growth and spread.
This ophthalmic solution provides rapid relief from redness, swelling, and discomfort while ensuring broad-spectrum antibacterial protection. Moxolunic Eye Drop is WHO-GMP certified and suitable for pharma export, third-party manufacturing, and PCD pharma franchise opportunities.
Some individuals may experience mild irritation, burning, or a stinging sensation after applying the eye drops. Other possible side effects include redness, itching, dryness, excessive tearing, or temporary blurred vision. In rare cases, severe allergic reactions such as swelling, persistent pain, or worsening infection may occur, requiring immediate medical attention.
Moxolunic Eye Drop is used to treat bacterial eye infections, including conjunctivitis (pink eye), corneal ulcers, and other ocular bacterial conditions. It helps reduce symptoms like redness, swelling, irritation, and discharge caused by bacterial infections.
This medication is for external use only and should be used as directed by a healthcare professional. Avoid touching the dropper tip to any surface, including the eye, to prevent contamination. Contact lenses should be removed before application and reinserted at least 15 minutes after use. Completing the full course of treatment is crucial to prevent bacterial resistance and ensure effective recovery.
Moxolunic Eye Drop should be stored in a cool, dry place below 25°C, away from direct sunlight. It should not be frozen, and the bottle must be kept tightly closed to prevent contamination. The solution should be discarded one month after opening to maintain sterility. Keep it out of reach of children.
Composition : Moxifloxacin (5% w/v) + Betamethasone (0.1% w/v)
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin IP 400 mg + Mannitol IP 5.0% w/v Infusuion
Composition : Moxifloxacin (0.5% w/v) + Dexamethasone (0.1% w/v)
Composition : Moxifloxacin (0.5% w/v) + Difluprednate (0.05% w/v)
Composition : Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin HCL I.P. 0.5% w/v + Ketorolac Tromethsmine I.P. 5% w/v Eye Drop
Composition : Loteprednol etabonate (0.5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Composition : Moxifloxacin (400mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Moxifloxacin 0.5% w/v Eye Drops have strong demand in the ophthalmology, anti-infective, and specialty eye care segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ophthalmic and prescription healthcare portfolios.
Moxifloxacin 0.5% w/v Eye Drops have strong demand in the ophthalmology, anti-infective, and specialty eye care segment, making them a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on ophthalmic and prescription healthcare portfolios. Why should medical distributors include Moxifloxacin 0.5% w/v Eye Drops in their product range? Medical distributors and agencies can benefit from consistent demand for bacterial eye infection management under medical supervision. Moxifloxacin 0.5% w/v is a fourth-generation fluoroquinolone antibiotic used to treat susceptible bacterial infections of the eye Commonly prescribed for the treatment of bacterial conjunctivitis, keratitis, corneal ulcers, blepharitis, and other susceptible external ocular infections, as advised by ophthalmologists Helps inhibit bacterial DNA gyrase and topoisomerase IV, preventing bacterial replication and promoting effective elimination of susceptible bacteria Sterile eye drop formulation provides rapid local drug delivery with excellent ocular penetration and convenient topical administration Frequently used for the prevention and treatment of bacterial infections before and after ophthalmic surgical procedures, as recommended by eye specialists Should be used only under the supervision of a qualified healthcare professional and for the prescribed duration to support appropriate antibiotic use and help reduce the risk of antimicrobial resistance Frequently utilized in ophthalmology clinics, eye hospitals, specialty eye care centers, and day-care surgical facilities Widely prescribed by ophthalmologists and eye care specialists for appropriate bacterial ocular infections This strengthens a comprehensive ophthalmology and anti-infective eye care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Moxifloxacin 0.5% w/v Eye Drops with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent prescription demand, specialty ophthalmology market opportunities, hospital and institutional procurement, reliable supply chain support, repeat purchases, and attractive margins in the ophthalmic anti-infective segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality ophthalmic products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.